Epiphyseal growth plate and secondary peripheral chondrosarcoma: The neighbours matter

Journal of Pathology

Volumn 226, Issue 2, 2012, Pages 219-228

  De Andrea, Carlos E ^a   Hogendoorn, Pancras C W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

bone tumour; gradients; growth plate; osteochondroma; polarity; primary cilia; proteoglycans

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; EXT1 PROTEIN; EXT2 PROTEIN; HEPARAN SULFATE; MORPHOGEN; PROTEIN; PROTEOGLYCAN; UNCLASSIFIED DRUG; WNT PROTEIN;

BONE GROWTH; CELL POLARITY; CELL SURFACE; CHONDROSARCOMA; EPIPHYSIS; EXTRACELLULAR MATRIX; HOMOZYGOSITY; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECONDARY PERIPHERAL CHONDROSARCOMA; SIGNAL TRANSDUCTION; STEM CELL; WILD TYPE;

BONE NEOPLASMS; BONE REMODELING; CELL COMMUNICATION; CELL POLARITY; CHONDROSARCOMA; GROWTH PLATE; HOMOZYGOTE; HUMANS; MUTATION; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEOGLYCANS; TUMOR MICROENVIRONMENT;

EID: 82755189619     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.3003     Document Type: Review

References (83)

1. Campbell JT, Kaplan FS,. The role of morphogens in endochondral ossification. Calcif Tissue Int 1992; 50: 283-289.
2. Mariani FV, Martin GR,. Deciphering skeletal patterning: clues from the limb. Nature 2003; 423: 319-325. (Pubitemid 40852705)
3. DeLise AM, Fischer L, Tuan RS,. Cellular interactions and signaling in cartilage development. Osteoarthr Cartilage 2000; 8: 309-334.
4. Hacker U, Nybakken K, Perrimon N,. Heparan sulphate proteoglycans: the sweet side of development. Nat Rev Mol Cell Biol 2005; 6: 530-541. (Pubitemid 40943044)
5. Willems SM, Wiweger M, Frans Graadt van Roggen J, et al., Running GAGs: myxoid matrix revisited. What's in it for the pathologist? Virchows Arch 2009; 456: 181-192.
6. Kronenberg HM,. Developmental regulation of the growth plate. Nature 2003; 423: 332-336. (Pubitemid 40852707)
7. Dodds GS,. Row formation and other types of arrangement of cartilage cells in endochondral ossification. Anat Rec 1930; 46: 385-399.
8. Song B, Haycraft CJ, Seo H, et al., Development of the post-natal growth plate requires intraflagellar transport proteins. Dev Biol 2007; 305: 202-216. (Pubitemid 46589413)
9. Li Y, Dudley AT,. Noncanonical frizzled signaling regulates cell polarity of growth plate chondrocytes. Development 2009; 136: 1083-1092.
10. Grashoff C, Aszodi A, Sakai T, et al., Integrin-linked kinase regulates chondrocyte shape and proliferation. EMBO Rep 2003; 4: 432-438. (Pubitemid 36622011)
11. Reverte CG, Benware A, Jones CW, et al., Perturbing integrin function inhibits microtubule growth from centrosomes, spindle assembly, and cytokinesis. J Cell Biol 2006; 174: 491-497. (Pubitemid 44231861)
12. 1 progression, and cytokinesis. Genes Dev 2003; 17: 2465-2479. (Pubitemid 37214793)
13. Wolpert L,. Positional information and pattern formation in development. Dev Genet 1994; 15: 485-490.
14. Wolpert L,. Positional information revisited. Development 1989; 107 (suppl): 3-12. (Pubitemid 20055049)
15. Tickle C,. Making digit patterns in the vertebrate limb. Nat Rev Mol Cell Biol 2006; 7: 45-53. (Pubitemid 43361571)
16. Salinas PC,. Signaling at the vertebrate synapse: new roles for embryonic morphogens? J Neurobiol 2005; 64: 435-445. (Pubitemid 41114051)
17. Yan D, Lin X,. Shaping morphogen gradients by proteoglycans. Cold Spring Harb Perspect Biol 2009; 1: a002493.
18. Wu Y, Belenkaya TY, Lin X,. Dual roles of Drosophila glypican Dally-like in Wingless/Wnt signaling and distribution. Methods Enzymol 2010; 480: 33-50.
19. Cortes M, Baria AT, Schwartz NB,. Sulfation of chondroitin sulfate proteoglycans is necessary for proper Indian hedgehog signaling in the developing growth plate. Development 2009; 136: 1697-1706.
20. de Andrea CE, Prins FA, Wiweger MI, et al., Growth plate regulation and osteochondroma formation: insights from tracing proteoglycans in zebrafish models and human cartilage. J Pathol 2011; 224: 160-168.
21. Minina E, Wenzel HM, Kreschel C, et al., BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development 2001; 128: 4523-4534. (Pubitemid 33130432)
22. Vortkamp A, Lee K, Lanske B, et al., Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 1996; 273: 613-622. (Pubitemid 26262108)
23. Zhang D, Schwarz EM, Rosier RN, et al., ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development. J Bone Miner Res 2003; 18: 1593-1604. (Pubitemid 37022917)
24. Bornens M,. Organelle positioning and cell polarity. Nat Rev Mol Cell Biol 2008; 9: 874-886.
25. Jones C, Chen P,. Planar cell polarity signaling in vertebrates. BioEssays 2007; 29: 120-132. (Pubitemid 46340247)
26. Fuerer C, Habib SJ, Nusse R,. A study on the interactions between heparan sulfate proteoglycans and Wnt proteins. Dev Dyn 2010; 239: 184-190.
27. Zallen JA,. Planar polarity and tissue morphogenesis. Cell 2007; 129: 1051-1063. (Pubitemid 46891047)
28. Andersson ER, Prakash N, Cajanek L, et al., Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivo. PLoS ONE 2008; 3: e3517.
29. Wheatley DN, Feilen EM, Yin Z, et al., Primary cilia in cultured mammalian cells: detection with an antibody against detyrosinated α-tubulin (ID5) and by electron microscopy. J Submicrosc Cytol Pathol 1994; 26: 91-102. (Pubitemid 2044089)
30. Poole CA, Flint MH, Beaumont BW,. Analysis of the morphology and function of primary cilia in connective tissues: a cellular cybernetic probe? Cell Motil 1995; 5: 175-193.
31. Singla V, Reiter JF,. The primary cilium as the cell's antenna: signaling at a sensory organelle. Science 2006; 313: 629-633. (Pubitemid 44201133)
32. Denman-Johnson K, Forge A,. Establishment of hair bundle polarity and orientation in the developing vestibular system of the mouse. J Neurocytol 1999; 28: 821-835. (Pubitemid 30618062)
33. Tilney LG, Cotanche DA, Tilney MS,. Actin filaments, stereocilia and hair cells of the bird cochlea. VI. How the number and arrangement of stereocilia are determined. Development 1992; 116: 213-226.
34. de Andrea CE, Wiweger M, Prins F, et al., Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma. Lab Invest 2010; 90: 1091-1101.
35. Park TJ, Mitchell BJ, Abitua PB, et al., Dishevelled controls apical docking and planar polarization of basal bodies in ciliated epithelial cells. Nat Genet 2008; 40: 871-879. (Pubitemid 351913644)
36. Eggenschwiler JT, Anderson KV,. Cilia and developmental signaling. Annu Rev Cell Dev Biol 2007; 23: 345-373.
37. Weise M, De Levi S, Barnes KM, et al., Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci USA 2001; 98: 6871-6876. (Pubitemid 32538309)
38. Faustini-Fustini M, Rochira V, Carani C,. Oestrogen deficiency in men: where are we today? Eur J Endocrinol 1999; 140: 111-129. (Pubitemid 29090438)
39. Baron J, Klein KO, Colli MJ, et al., Catch-up growth after glucocorticoid excess: a mechanism intrinsic to the growth plate. Endocrinology 1994; 135: 1367-1371. (Pubitemid 24307510)
40. Warman ML, Cormier-Daire V, Hall C, et al., Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A 2011; 155A: 943-968.
41. Bovee JVMG, Hogendoorn PCW, Wunder JS, et al., Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nat Rev Cancer 2010; 10: 481-488.
42. Hameetman L, Szuhai K, Yavas A, et al., The Role of EXT1 in non hereditary osteochondroma: identification of homozygous deletions. J Natl Cancer Inst 2007; 99: 396-406. (Pubitemid 47073483)
43. Wuyts W, Van Hul W,. Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Hum Mutat 2000; 15: 220-227. (Pubitemid 30132156)
44. Bovee JVMG, Cleton-Jansen AM, Wuyts W, et al., EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet 1999; 65: 689-698. (Pubitemid 30468713)
45. Stickens D, Clines G, Burbee D, et al., The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nat Genet 1996; 14: 25-32. (Pubitemid 26301543)
46. Ahn J, Ludecke H-J, Lindow S, et al., Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat Genet 1995; 11: 137-143.
47. McCormick C, Duncan G, Goutsos KT, et al., The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA 2000; 97: 668-673. (Pubitemid 30070367)
48. Busse M, Feta A, Presto J, et al., Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation. J Biol Chem 2007; 282: 32802-32810. (Pubitemid 350159291)
49. Bernfield M, Gotte M, Park PW, et al., Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999; 68: 729-777. (Pubitemid 29449208)
50. van den Berg H, Kroon HM, Slaar A, et al., Incidence of biopsy-proven bone tumors in children: a report based on the Dutch pathology registration 'PALGA'. J Pediatr Orthop 2008; 28: 29-35. (Pubitemid 351628188)
51. Khurana J, Abdul-Karim F, Bovée JVMG,. Osteochondroma. In World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, Fletcher CDM, Unni KK, Mertens F, (eds). IARC Press: Lyons, France, 2002; 234-236.
52. Stieber JR, Dormans JP,. Manifestations of hereditary multiple exostoses. J Am Acad Orthop Surg 2005; 13: 110-120.
53. Romeo S, Hogendoorn PC, Dei Tos AP,. Benign cartilaginous tumors of bone: from morphology to somatic and germ-line genetics. Adv Anat Pathol 2009; 16: 307-315.
54. Jennes I, de JD, Mees K, et al., Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 multiple osteochondromas families. BMC Med Genet 2011; 12: 85.
55. Hameetman L, David G, Yavas A, et al., Decreased EXT expression and intracellular accumulation of HSPG in osteochondromas and peripheral chondrosarcomas. J Pathol 2007; 211: 399-409. (Pubitemid 46332551)
56. Reijnders CM, Waaijer CJ, Hamilton A, et al., No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas. Am J Pathol 2010; 177: 1946-1957.
57. Zuntini M, Pedrini E, Parra A, et al., Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation. Oncogene 2010; 29: 3827-3834.
58. Szuhai K, Jennes I, De Jong D, et al., Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients. Hum Mutat 2011; 32: 2036-2049.
59. Wiweger MI, Avramut CM, de Andrea CE, et al., Cartilage ultrastructure in proteoglycan-deficient zebrafish mutants brings to light new candidate genes for human skeletal disorders. J Pathol 2011; 223: 531-542.
60. Clément A, Wiweger M, von der Hardt S, et al., Regulation of zebrafish skeletogenesis by ext2/dackel and papst1/pinscher. PLoS Genet 2008; 4: e1000136.
61. Jones KB, Piombo V, Searby C, et al., A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes. Proc Natl Acad Sci USA 2010; 107: 2054-2059.
62. Matsumoto K, Irie F, Mackem S, et al., A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses. Proc Natl Acad Sci USA 2010; 107: 10932-10937.
63. Du K, Peng Y, Zhang L, et al., Expression of the stem cell marker nestin in pre/hypertrophic chondrocytes in osteochondroma. J Int Med Res 2011; 39: 348-357.
64. Faraci M, Bagnasco F, Corti P, et al., Osteochondroma after hematopoietic stem cell transplantation in childhood. An Italian study on behalf of the AIEOP-HSCT group. Biol Blood Marrow Transpl 2009; 15: 1271-1276.
65. Bordigoni P, Turello R, Clement L, et al., Osteochondroma after pediatric hematopoietic stem cell transplantation: report of eight cases. Bone Marrow Transpl 2002; 29: 611-614. (Pubitemid 34537723)
66. Hilton MJ, Gutierrez L, Martinez DA, et al., EXT1 regulates chondrocyte proliferation and differentiation during endochondral bone development. Bone 2005; 36: 379-386. (Pubitemid 40403836)
67. de Andrea CE, Reijnders CM, Kroon HM, et al., Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT. Oncogene 2011; DOI: 10.1038/onc.2011.311.
68. Passanise AM, Mehlman CT, Wall EJ, et al., Radiographic evidence of regression of a solitary osteochondroma: a report of 4 cases and a literature review. J Pediatr Orthop 2011; 31: 312-316.
69. Bissell MJ, Hines WC,. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2011; 17: 320-329.
70. Allen M, Louise JJ,. Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol 2011; 223: 162-176.
71. Yen KE, Bittinger MA, Su SM, et al., Cancer-associated IDH mutations: biomarker and therapeutic opportunities. Oncogene 2010; 29: 6409-6417.
72. Raaijmakers MH, Mukherjee S, Guo S, et al., Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 2010; 464: 852-857.
73. Huang JN, Shimamura A,. Clinical spectrum and molecular pathophysiology of Shwachman-Diamond syndrome. Curr Opin Hematol 2011; 18: 30-35.
74. Raaijmakers M,. Niche contributions to oncogenesis: emerging concepts and implications for the hematopoietic system. Haematologica 2011; 96: 1041-1048.
75. Bertoni F, Bacchini P, Hogendoorn PCW,. Chondrosarcoma. In World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, Fletcher CDM, Unni KK, Mertens F, (eds). IARC Press: Lyons, France, 2002; 247-251.
76. Amary MF, Bacsi K, Maggiani F, et al., IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 2011; 224: 334-343.
77. Hallor KH, Staaf J, Bovée JVMG, et al., Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors. Clin Cancer Res 2009; 15: 2685-2694.
78. Bovée JVMG, Royen Mv, Bardoel AFJ, et al., Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma. Am J Pathol 2000; 157: 1587-1595.
79. Bovée JVMG, Sciot R, Dal Cin P, et al., Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes. Diagn Mol Pathol 2001; 10: 228-236.
80. Mohseny AB, Hogendoorn PCW,. Concise review: mesenchymal tumors: when stem cells go mad. Stem Cells 2011; 29: 397-403.
81. Boeuf S, Kunz P, Hennig T, et al., A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma. J Pathol 2008; 216: 158-166.
82. Reijmers RM, Groen RW, Rozemuller H, et al., Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma. Blood 2010; 115: 601-604.
83. Rozeman LB, de Bruijn IH, Bacchini P, et al., Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes. Mod Pathol 2009; 22: 1489-1498.